Literature DB >> 5937676

Urates and kinin formation in synovial fluid.

V Eisen.   

Abstract

Mesh：

Substances：

Year:  1966        PMID： 5937676      PMCID： PMC1900613     

Source DB:  PubMed          Journal:  Proc R Soc Med        ISSN： 0035-9157


× No keyword cloud information.
  11 in total

1.  PROTEOLYTIC ACTIVITY AND CONNECTIVE TISSUE.

Authors:  C H LACK
Journal:  Br Med Bull       Date:  1964-09       Impact factor: 4.291

2.  ACTIVATION OF HAGEMAN FACTOR BY SOLUTIONS OF ELLAGIC ACID.

Authors:  O D RATNOFF; J D CRUM
Journal:  J Lab Clin Med       Date:  1964-03

3.  SOLUBILITY OF SODIUM URATE IN THE PRESENCE OF CHONDROITIN-4-SULPHATE.

Authors:  T C LAURENT
Journal:  Nature       Date:  1964-06-27       Impact factor: 49.962

4.  "STUDIES ON THE NATURE OF GOUTY TOPHI" BY MAX FREUDWEILER, 1899. (AN INFLAMMATORY RESPONSE TO INJECTED SODIUM URATE, 1899). AN ABRIDGED TRANSLATION, WITH COMMENTS.

Authors:  J M BRILL; D J MCCARTY
Journal:  Ann Intern Med       Date:  1964-03       Impact factor: 25.391

Review 5.  LYSOSOMES.

Authors:  G WEISSMANN
Journal:  Blood       Date:  1964-11       Impact factor: 22.113

6.  THE INFLAMMATORY PROCESS IN ACUTE GOUTY ARTHRITIS. I. ACTIVATION OF HAGEMAN FACTOR BY SODIUM URATE CRYSTALS.

Authors:  R W KELLERMEYER; R T BRECKENRIDGE
Journal:  J Lab Clin Med       Date:  1965-02

7.  Biochemistry of uric acid and its relation to gout.

Authors:  J E SEEGMILLER; L LASTER; R R HOWELL
Journal:  N Engl J Med       Date:  1963-03-28       Impact factor: 91.245

8.  Activation of plasma by contact with glass: evidence for a common reaction which releases plasma kinin and initiates coagulation.

Authors:  J MARGOLIS
Journal:  J Physiol       Date:  1958-11-10       Impact factor: 5.182

9.  Suppression of metabolic accompaniments of phagocytosis by colchicine.

Authors:  S E Goldfinger; R R Howell; J E Seegmiller
Journal:  Arthritis Rheum       Date:  1965-12

10.  Factors affecting the adhesiveness of human leucocytes and platelets in vitro.

Authors:  J E GARVIN
Journal:  J Exp Med       Date:  1961-07-01       Impact factor: 14.307
View more
  12 in total

Review 1.  Kallikreins and kinins: mediators in inflammatory joint disease?

Authors:  K Worthy; C D Figueroa; P A Dieppe; K D Bhoola
Journal:  Int J Exp Pathol       Date:  1990-08       Impact factor: 1.925

2.  Gene signature extraction and cell identity recognition at the single-cell level with Cell-ID.

Authors:  Akira Cortal; Loredana Martignetti; Emmanuelle Six; Antonio Rausell
Journal:  Nat Biotechnol       Date:  2021-04-29       Impact factor: 54.908

3.  A novel relationship between plasma kininogen and rheumatoid.

Authors:  J N Sharma; I J Zeitlin; P M Brooks; W C Dick
Journal:  Agents Actions       Date:  1976-02

4.  Components of the fibrinolytic system in synovial joints. Normal bovine compared with normal and abnormal human synovial joints.

Authors:  D E Caughey; T C Highton
Journal:  Ann Rheum Dis       Date:  1967-07       Impact factor: 19.103

5.  Reversible deficit on a delayed alternation task during subcortical cooling.

Authors:  G Krauthamer; J Liebeskind; A Salmon-Legagneur
Journal:  J Physiol       Date:  1967-05       Impact factor: 5.182

6.  Intracellular enzymes and kinin enzymes in synovial fluid in joint diseases. Origin and relation to disease category.

Authors:  M K Jasani; M Katori; G P Lewis
Journal:  Ann Rheum Dis       Date:  1969-09       Impact factor: 19.103

7.  Plasma kinins in synovial exudates.

Authors:  V Eisen
Journal:  Br J Exp Pathol       Date:  1970-06

8.  The chemistry of pain production.

Authors:  C A Keele
Journal:  Proc R Soc Med       Date:  1967-04

9.  Sickle cell disease associated with uric acid deposition disease.

Authors:  B M Rothschild; C W Sienknecht; S B Kaplan; J S Spindler
Journal:  Ann Rheum Dis       Date:  1980-08       Impact factor: 19.103

10.  A tissue kallikrein in the synovial fluid of patients with rheumatoid arthritis.

Authors:  B M Selwyn; C D Figueroa; E Fink; A Swan; P A Dieppe; K D Bhoola
Journal:  Ann Rheum Dis       Date:  1989-02       Impact factor: 19.103
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.